1. Michelini, Sandro, Ricci, Maurizio, Veselenyiova, Dominika, Dautaj, Astrit, Bertelli, Matteo. 2020. TIE1 as a Candidate Gene for Lymphatic Malformations with or without Lymphedema. In International journal of molecular sciences, 21, . doi:10.3390/ijms21186780. https://pubmed.ncbi.nlm.nih.gov/32947856/
2. Liu, Pan, Xie, Lisha, Wu, Qiulei, Yang, Ping, Cai, Liqiong. 2024. TIE1 promotes cervical cancer progression via Basigin-matrix metalloproteinase axis. In International journal of biological sciences, 20, 2297-2309. doi:10.7150/ijbs.93667. https://pubmed.ncbi.nlm.nih.gov/38617545/
3. Brouillard, Pascal, Murtomäki, Aino, Leppänen, Veli-Matti, Alitalo, Kari, Vikkula, Miikka. 2024. Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema. In The Journal of clinical investigation, 134, . doi:10.1172/JCI173586. https://pubmed.ncbi.nlm.nih.gov/38820174/
4. Gong, Zhenqi, Zheng, Qing, Li, Baizhi, Chen, Hongwu, Lin, Shaoxiong. 2024. Identification of the Expression of TIE1 and Its Mediated Immunosuppression in Gastric Cancer. In Journal of Cancer, 15, 2994-3009. doi:10.7150/jca.90891. https://pubmed.ncbi.nlm.nih.gov/38706903/
5. Li, Xiaoyan, Shen, Aotian, Zhao, Yiran, Xia, Junfeng. . Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders. In Schizophrenia bulletin, 49, 1305-1315. doi:10.1093/schbul/sbad100. https://pubmed.ncbi.nlm.nih.gov/37418754/
6. Liu, Jiewei, Cheng, Yuqi, Li, Ming, Li, Tao, Luo, Xiong-Jian. 2022. Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders. In Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 48, 270-280. doi:10.1038/s41386-022-01456-5. https://pubmed.ncbi.nlm.nih.gov/36114287/
智鼠故事 
